Nanion Technologies

04. - 08.02.2017 | SLAS

Venue: Walter E. Washington Convention Center, Washington DC, USA

Come to our booth #1311 and meet Tim Strassmaier.

 

We will present a joint poster together with Axiogenesis. Title: "Non-integrating, transient optogenetic modification of human iPSC-derived cardiomyocytes using ChR2 and GCaMP6f mRNAs". Read the abstract here.

 

Do not miss the Tutorial of our collaboration partner Genedata on Tuesday, February 7th at 9:30 AM - 10:15 AM, room: 143B:

Title: "Effortlessly scaling up automated patch clamp research with Genedata screener".

Abstract: "This tutorial will show how the capabilities of Genedata Screener for Ion Channel Screening have been expanded with our latest software release. Screener now allows effortless scale-up of automated patch clamp (APC) research with improved experimental overview and comparisons within and across experiments. These new capabilities will be exemplified with our latest Ready-to-Run integration: the Nanion SyncroPatch 384PE. We will show how all QC parameters, compound information and cursor names are directly imported, allowing automatic and coherent evaluation of data, and thereafter present prototypical assays from a compound screening and safety viewpoint, with titrations performed both with cumulative addition and across wells. We will also outline further processing capabilities, e.g. specific control wells enabling per-sweep normalization, before we conclude by providing an enterprise workflow perspective for modern ion channel pharma research."

 

A joint poster will be presented by Genedata and AstraZeneca showing data of the SyncroPatch 384PE.

Title: "A new analysis pipeline to improve assessment of cardiac liability in high throughput electrophysiology screens with routine MoA detection for slow onset compounds". Read the abstract here.

 

Go to the Conference website here.